Loading...
Loading...
Global Hunter Securities has initiated coverage on MediciNova
MNOV with a Buy rating and $4 price target.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Price TargetInitiationAnalyst RatingsBiotechnologyGlobal Hunter SecuritiesHealth Caremedicinova
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in